Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXON
2251
Axon Enterprise
AXON
$49.8B
| $12.4M | ﹤0.01% |
101,041
+33,971
| +51% | +$3.9M |
|
2252
Albertsons Companies
ACI
$6.03B
| $12.4M | ﹤0.01% |
703,143
-3,976,792
| -85% | -$60.3M |
|
2253
PUT
Cardinal Health
CAH
$54.7B
| $12.4M | ﹤0.01% |
230,700
-193,400
| -46% | -$10M |
|
2254
Olin
OLN
$2.18B
| $12.4M | ﹤0.01% |
503,089
-1,016
| -0.2% | -$20.7K |
|
2255
CALL
Penumbra
PEN
$12.9B
| $12.4M | ﹤0.01% |
70,600
+59,700
| +548% | +$13.1M |
|
2256
PUT
F5
FFIV
$22.8B
| $12.4M | ﹤0.01% |
70,200
-15,600
| -18% | -$2.37M |
|
2257
Nokia
NOK
$60.1B
| $12.4M | ﹤0.01% |
3,158,948
+208,125
| +7% | +$820K |
|
2258
PUT
Alaska Air
ALK
$5.13B
| $12.3M | ﹤0.01% |
237,500
+4,400
| +2% | +$198K |
|
2259
CALL
Stellantis
STLA
$20.2B
| $12.3M | ﹤0.01% |
682,600
+330,400
| +94% | +$4.87M |
|
2260
State Street SPDR Portfolio Corporate Bond ETF
SPBO
$2.09B
| $12.3M | ﹤0.01% |
340,317
+211,371
| +164% | +$7.56M |
|
2261
FuelCell Energy
FCEL
$1.79B
| $12.3M | ﹤0.01% |
36,761
+30,627
| +499% | +$5.01M |
|
|
GWPH
2262
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $12.3M | ﹤0.01% |
106,700
+19,400
| +22% | +$2.17M |
|
|
SPR
2263
PUT
DELISTED
Spirit AeroSystems
SPR
| $12.3M | ﹤0.01% |
314,900
+84,200
| +36% | +$2.41M |
|
|
APHA
2264
PUT
DELISTED
Aphria Inc. Common Shares
APHA
| $12.3M | ﹤0.01% |
1,776,300
+77,000
| +5% | +$480K |
|
2265
CALL
Copart
CPRT
$29.3B
| $12.3M | ﹤0.01% |
385,600
-85,600
| -18% | -$2.49M |
|
2266
PUT
ProShares UltraPro Dow 30
UDOW
$924M
| $12.3M | ﹤0.01% |
478,400
+72,000
| +18% | +$1.6M |
|
2267
CALL
LyondellBasell Industries
LYB
$20.6B
| $12.2M | ﹤0.01% |
133,600
-58,900
| -31% | -$4.8M |
|
2268
Columbia Sportswear
COLM
$2.94B
| $12.2M | ﹤0.01% |
140,101
+103,868
| +287% | +$9.03M |
|
2269
Schwab International Small-Cap Equity ETF
SCHC
$5.71B
| $12.2M | ﹤0.01% |
325,045
+297,703
| +1,089% | +$10.4M |
|
2270
PUT
ProShares Ultra QQQ
QLD
$14.4B
| $12.2M | ﹤0.01% |
424,800
+62,400
| +17% | +$1.58M |
|
2271
ProShares UltraPro Short QQQ
SQQQ
$1.68B
| $12.2M | ﹤0.01% |
6,426
-3,782
| -37% | -$9.17M |
|
2272
PUT
AES
AES
$10.5B
| $12.2M | ﹤0.01% |
518,000
+349,700
| +208% | +$7.27M |
|
2273
Expeditors International
EXPD
$24.2B
| $12.2M | ﹤0.01% |
+127,944
| New | +$11.7M |
|
2274
NovoCure
NVCR
$1.97B
| $12.1M | ﹤0.01% |
70,167
-138,882
| -66% | -$19M |
|
2275
PUT
Nutrien
NTR
$32.6B
| $12.1M | ﹤0.01% |
252,100
-71,400
| -22% | -$3.16M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.